Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis Theme

1-677-124-44227

184 MAIN COLLINS STREET WEST VICTORIA 8007

FOLLOW US ON INSTAGRAM
Etiam ultricies nisi vel augue. Curabitur ullamcorper ultricies
Next day delivery for UAE. Middle East & Asia 3-5 days. For all Limitless US Products - Shipping will be 7-10 days
Top
 

Articles

How Peptide Therapy Supports Lyme Disease Recovery

Chronic conditions such as ongoing infections, persistent inflammation, and immune system imbalance can be difficult to manage with conventional treatment alone.Peptide Therapy is a valuable addition to Lyme disease protocols, by supporting immunity, reducing inflammation, and promoting tissue repair.Lyme disease has become a growing focus of Peptide Therapy due to the lingering symptoms that often persist even after antibiotic treatment.Several peptides may help regulate immune function, break down bacterial biofilms (protective bacterial clusters), and restore energy production at the cellular level, all of which are key to recovery from Lyme disease. What is Lyme Disease?Lyme disease is an infectious condition caused...

Is Natural MOTS-c Superior to Synthetic SS-31 for Mitochondrial Health?

Mitochondria are known as the "powerhouses" of cells, and are always at the center of discussions around aging, disease progression, and metabolic wellness.In this context, two peptides MOTS-c and SS-31 have garnered attention for their unique roles in enhancing mitochondrial performance.MOTS-c, a naturally derived peptide encoded by mitochondrial DNA, and SS-31, a synthetic compound that protects mitochondrial structure, offer two very different yet promising approaches to addressing mitochondrial dysfunction. Their mechanisms, applications, and benefits vary significantly, highlighting distinct therapeutic pathways: one guided by nature, the other engineered by design.Table of ContentsIntroduction2. What Are MOTS-c and SS-31?3. Why Use Mitochondrial Peptides4. Comparing...

Understanding the Difference Between Retatrutide, Semaglutide, and Tirzepatide

With the ongoing advancements in metabolic health and weight management, three Peptide-Based Therapies have become the focus of significant research and public interest.Retatrutide, Semaglutide and Tirzepatide are designed to influence hormonal pathways that regulate insulin sensitivity, glucose metabolism, and appetite control.While they all interact with incretin-related hormone systems, each one is unique in its structure, biological targets, and the extent of therapeutic benefit.The rise in conversations about weight loss medications makes it critical to understand how these treatments differ and what each offers in managing obesity and related metabolic disorders.Table of ContentsWhat Are Retatrutide, Semaglutide and Tirzepatide Why Use Hormone-Based Therapies?Mechanisms...

LL-37 vs KPV: Which Peptide Offers Superior Therapeutic Potential?

.post-26613 h2{font-size:24px!important;}.mkd-post-content h2,.mkd-post-content h3,.mkd-post-content h4,.mkd-post-content h5,.mkd-post-content h6{margin-top:28px!important;margin-bottom:28px!important;}.mkd-post-content p,.mkd-post-content ul li{font-size:17px!important;line-height:33px!important;}ul{list-style-position:outside;padding-left:1.5em;}ul li{text-indent:-1em;padding-left:1em;} Antimicrobial research is rapidly evolving as scientists look for new options beyond traditional antibiotics. Two promising peptide compounds, LL-37 and KPV, are gaining attention. Both of these peptides offer different ways to fight harmful microbes and reduce inflammation, each with its own mode of action and possible health benefits. Table of Contents: Understanding Anti-Microbial Peptides.  Understanding LL-37's Key Mechanisms of Action and Studies. Understanding KPV's Key Mechanism of Action and Studies.  LL-37 vs KPV.  Safety, Tolerance, Manufacturing and Stability of LL-37 and KPV.  How To Combine LL-37 and KPV.  How To Administer LL-37...

The history of peptide bioregulators

Today Professor Vladimir Khavinson is the President of the European Academy of Gerontology and Geriatrics, but in the 1980’s he was a Colonel in the Soviet Union military medical corps. At the time, he and his team were approached by Kremlin officials, they wanted them to find a way to protect their troops from a myriad of problems; issues such as radiation for submariners in nuclear submarines to troops that may be blinded from known, (but thankfully unused) new weapons such as battlefield lasers....